Skip to main content

Table 2 Absolute cells count in peripheral blood at basal, 2 m and 6 m of anti-TB therapy

From: Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time

Absolute cells count DS-TB (N = 13) DR-TB (N = 7)
Basal   
 Leukocytes, media (SD), (RV 4–10 × 103 cells/mm3) 11.5 (3.40) 9.98 (3.03)
 Neutrophils, media (SD), (RV 2–7.5 × 103 cells/mm3) 8.95 (3.5) 7.67 (2.87)
 Lymphocytes, media (SD), (RV 1–4 × 103 cells/mm3) 1.72 (0.78) 1.6 (0.33)
 Monocytes, media (SD), (RV 0.2–1 × 103 cells/mm3) 0.87 (0.48) 0.66 (0.24)
2 months of anti-TB therapy   
 Leukocytes, media (SD), (RV 4–10 × 103 cells/mm3) 6.75 (2.39) 6.8 (1.85)
 Neutrophils, media (SD), (RV 2–7.5 × 103 cells/mm3) 4.0 (2.36) 4.47 (1.41)
 Lymphocytes, media (SD), (RV 1–4 × 103 cells/mm3) 1.80 (0.86) 1.45 (0.57)
 Monocytes, media (SD), (RV 0.2–1 × 103 cells/mm3) 0.51 (0.31) 0.72 (0.19)
6 months of anti-TB therapy   
 Leukocytes, media (SD), (RV 4–10 × 103 cells/mm3) 6.8 (1.86) 6.35 (1.50)
 Neutrophils, media (SD), (RV 2–7.5 × 103 cells/mm3) 4.03 (1.53) 4.07 (1.16)
 Lymphocytes, media (SD), (RV 1–4 × 103 cells/mm3) 2.01 (0.69) 1.41 (0.41)
 Monocytes, media (SD), (RV 0.2–1 × 103 cells/mm3) 0.56 (0.24) 0.62 (0.13)
  1. DS-TB drug-susceptible tuberculosis, DR-TB drug-resistant tuberculosis, SD standard deviation, RV reference value (provided by the institutional Clinical Laboratory)